Earnings History Data for Amgen Inc. (AMGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Amgen Inc.

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
30-10-2024	AH		AMGN	Amgen Inc.	170,420	5.58	5.11	4.96	Amgen Non-GAAP EPS of $5.58 beats by $0.47, revenue of $8.5B in-line [10/30/2024 4:03 PM]	320.64	5.10 (1.62%)	318.32	2.78 (0.88%)	249.70 - 346.85	1,798,772	1,680,000	5,568
Amgen Non-GAAP EPS of $5.58 beats by $0.47, revenue of $8.5B in-line [10/30/2024 4:03 PM] Amgen in charts: Prolia, XGEVA sales gain, while Enbrel continues to wind down in Q3 [10/30/2024 4:18 PM] Amgen updates 2024 guidance with revenue and EPS ranges including consensus [10/30/2024 5:40 PM] Pfizer Unveils Its Next Black Box In Obesity. It's Taking On Amgen. [Oct-29-24 04:11PM] AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS [2024-10-30 04:01PM] Amgen: Q3 Earnings Snapshot [2024-10-30 04:09PM] Amgen posts higher 3rd-quarter profit, sales rise 24% [2024-10-30 04:03PM] Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO [2024-10-30 04:01PM] Amgen posts higher profit, obesity data on track for late this year [2024-10-30 04:03PM] Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics [2024-10-30 05:30PM] Amgen (AMGN) Beats Q3 Earnings Estimates [2024-10-30 05:15PM] Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ... [2024-10-31 03:21AM] Amgen (AMGN) Q3 2024 Earnings Call Transcript [Oct-30-24 08:15PM] Analyst Report: Amgen Inc. [2024-10-31 09:28AM] Amgen earns higher revenues in Q3 2024, puts rare diseases in the spotlight [2024-10-31 01:48PM] Q3 2024 Amgen Inc Earnings Call [2024-10-31 01:39PM]
06-08-2024	AH		AMGN	Amgen Inc.	179,990	4.97	4.93	5.00	Amgen Non-GAAP EPS of $4.97 misses by $0.03, revenue of $8.39B beats by $40M [8/6/2024 4:02 PM]	311.98	-16.97 (-5.16%)	321.00	-7.95 (-2.42%)	243.46 - 346.85	3,536,251	2,160,000	43,986
Amgen Non-GAAP EPS of $4.97 misses by $0.03, revenue of $8.39B beats by $40M [8/6/2024 4:02 PM] Amgen in charts: Sales of Prolia, XGEVA continue to gain Y/Y, Enbrel and Otezla fall in Q2 [8/6/2024 4:11 PM] Amgen narrows guidance ranges for 2024 EPS, revenue [8/6/2024 5:23 PM] Amgen cut at Wells Fargo; says obesity success is already priced in [8/7/2024 8:18 AM]
02-05-2024	AH		AMGN	Amgen Inc.	148,120	3.96	3.76	3.98	Amgen Non-GAAP EPS of $3.96 beats by $0.05, revenue of $7.45B in-line [5/2/2024 4:03 PM]	310.81	32.42 (11.65%)	313.00	34.61 (12.43%)	211.71 - 329.72	8,466,849	2,540,000	337,015
Amgen in charts: Major drug sales grow at slower pace Y/Y, rev from Enbrel dips in Q1 [5/2/2024 4:16 PM] Amgen stock rallies 13% amid weight-loss drug updates, tweaked guidance [5/2/2024 5:40 PM] Biggest stock movers today: WOW, AAPL, SQ, and more [5/3/2024 10:00 AM] Amgen stock rallies 13% on GLP-1 weight-loss drug update [5/3/2024 10:28 AM] William Blair, Barclays upgrade Amgen following GLP-1 drug update [5/3/2024 12:29 PM]
06-02-2024	AH		AMGN	Amgen Inc.	172,960	4.71	4.66	4.09	Amgen Non-GAAP EPS of $4.71 beats by $0.12, revenue of $8.2B beats by $90M [2/6/2024 4:03 PM]	296.26	-19.81 (-6.27%)	313.00	-3.07 (-0.97%)	211.71 - 329.72	6,734,937	3,030,000	335,127
Amgen Non-GAAP EPS of $4.71 beats by $0.12, revenue of $8.2B beats by $90M [2/6/2024 4:03 PM] Amgen in charts: Q4 sales for Prolia, XGEVA, and Otezla rise, while Enbrel dips Y/Y [2/6/2024 4:18 PM] Amgen cut at Leerink on heavy obesity expectations [2/7/2024 9:34 AM]
31-10-2023	PM		AMGN	Amgen Inc.	144,270	4.96	4.65	4.70	Amgen Non-GAAP EPS of $4.96 beats by $0.28, revenue of $6.9B misses by $50M [10/31/2023 7:34 AM]	255.53	-7.66 (-2.91%)	255.06	-8.13 (-3.09%)	211.71 - 296.67	3,564,119	2,580,000	288,907
Amgen slated to release first earnings report since Horizon merger on Tuesday [10/30/2023 4:09 PM] Amgen Non-GAAP EPS of $4.96 beats by $0.28, revenue of $6.9B misses by $50M [10/31/2023 7:34 AM] Amgen in charts: Sales of Prolia, XGEVA surge on higher prices; Enbrel, Otezla fall Y/Y [10/31/2023 8:48 AM] Amgen stock erases gains despite outlook boost (update) [10/31/2023 9:53 AM]
03-08-2023	AH		AMGN	Amgen Inc.	124,030	5.00	4.44	4.65	Amgen Non-GAAP EPS of $5.00 beats by $0.51, revenue of $6.98B beats by $300M [8/3/2023 4:05 PM]	242.99	12.29 (5.33%)	237.05	6.35 (2.75%)	211.71 - 296.67	4,384,512	2,800,000	14,979
Amgen Non-GAAP EPS of $5.00 beats by $0.51, revenue of $6.98B beats by $300M [8/3/2023 4:05 PM] Amgen guides 2023 EPS above consensus while revenue in-line [8/3/2023 4:54 PM] Amgen says FTC has ignored commitments it made to address Horizon deal concerns (update) [8/3/2023 6:02 PM]
27-04-2023	AH	4:00 PM ET (Apr 27)	AMGN	Amgen Inc.	130,810	3.98	3.84	4.25	Amgen earnings preview: Will AMGN's streak of EPS beats continue in Q1? [4/26/2023 3:53 PM]	240.03	1.23 (0.52%)	239.00	0.20 (0.08%)	223.30 - 296.67	1,825,195	1,670,000	4,441
Amgen earnings preview: Will AMGN's streak of EPS beats continue in Q1? [4/26/2023 3:53 PM]
31-01-2023	AH	4:00 PM ET (Jan 31)	AMGN	Amgen Inc.	136,000	4.09	4.02	4.36	Amgen Non-GAAP EPS of $4.09 in-line, revenue of $6.8B beats by $30M [1/31/2023 4:02 PM]	246.18	-6.22 (-2.46%)	249.99	-2.41 (-0.95%)	214.39 - 296.67	4,515,682	2,250,000	45,954
Amgen's biosimilar of AbbVie's Humira enters US market [1/31/2023 6:40 AM] Horizon Therapeutics briefly ticked lower on report of FTC 2nd request in Amgen deal [1/31/2023 10:25 AM] Amgen Non-GAAP EPS of $4.09 in-line, revenue of $6.8B beats by $30M [1/31/2023 4:02 PM] Horizon Therapeutics confirms FTC Second Request in Amgen deal [1/31/2023 4:24 PM] Amgen 2023 EPS, revenue estimates within expectations; Lumakras, Evenity see big YoY gains [1/31/2023 5:19 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	AMGN	Amgen Inc.	145,530	4.70	4.43	4.67	Amgen Non-GAAP EPS of $4.70 beats by $0.25, revenue of $6.65B beats by $90M [11/3/2022 4:03 PM]	268.83	2.95 (1.11%)	261.59	-4.29 (-1.61%)	198.64 - 274.88	2,758,825	2,770,000	4,735
Amgen Non-GAAP EPS of $4.70 beats by $0.25, revenue of $6.65B beats by $90M [11/3/2022 4:03 PM] Amgen revises 2022 guidance as Q3 results beat on top and bottom lines [11/3/2022 5:12 PM] AMGEN TO WEBCAST INVESTOR CALL AT AHA 2022 [Nov-02-22 04:00PM] Drug, Biotech Stocks' Q3 Earnings on Nov 3: AMGN, REGN & More [Nov-02-22 09:25AM] Amgen's (NASDAQ:AMGN) five-year earnings growth trails the decent shareholder returns [Nov-02-22 07:00AM] 6 Stocks With Healthy Dividends and Solid Returns [Nov-02-22 03:30AM] 2 Dividend Stocks to Hold Through a Recession and Beyond [Nov-03-22 08:30AM] AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS [Nov-03-22 04:01PM] Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts [Nov-03-22 04:13PM] UPDATE 2-Amgen posts higher profit, says obesity drug data coming next month [Nov-03-22 04:33PM] Amgen posts higher profit, says obesity drug data coming next month [Nov-03-22 04:22PM] Amgen (AMGN) Surpasses Q3 Earnings and Revenue Estimates [Nov-03-22 05:15PM] Amgen Beats on Revenue and Profit Expectations [Nov-03-22 01:20PM] Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth [Nov-04-22 07:57AM] Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View [Nov-04-22 10:35AM] RPT-U.S. Supreme Court to hear Amgen bid to revive Repatha patents [Nov-04-22 01:40PM] U.S. Supreme Court to hear Amgen bid to revive Repatha patents [Nov-04-22 01:32PM] U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents [Nov-04-22 02:09PM] UPDATE 1-U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents [Nov-04-22 02:08PM] UPDATE 2-U.S. Supreme Court to hear Amgen bid to revive cholesterol drug patents [Nov-04-22 02:08PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	AMGN	Amgen Inc.	131,390	4.65	4.36	4.38		246.28	-0.70 (-0.28%)	245.30	-1.68 (-0.68%)	198.64 - 258.45	2,273,476	2,280,000	11,503
ChemoCentryx soars 109% as Amgen agrees to buy for $3.7B in cash [8/4/2022 8:44 AM] Amgen tops Q2 expectations; tightens FY22 revenue guidance [8/4/2022 4:02 PM] Amgen posts 2Q beat, trims earnings guidance; new drugs outperform [8/4/2022 4:30 PM] Amgen Aims To Stanch Generic Losses With $3.7 Billion ChemoCentryx Buyout [Aug-04-22 01:00PM] Amgen Acquires Drugmaker ChemoCentryx for $3.7 Billion [Aug-04-22 11:35AM] Big biotech to buy one-drug Peninsula company ChemoCentryx for $3.7 billion cash [Aug-04-22 11:16AM] Why ChemoCentryx Stock Is On Fire Today [Aug-04-22 10:08AM] ChemoCentryx Stock More Than Doubles On $4B Buyout [Aug-04-22 09:05AM] Amgen to gain rare-disease drug in $3.7 billion acquisition of ChemoCentryx [Aug-04-22 08:24AM] Amgen adds potential blockbuster drug with $3.7 billion ChemoCentryx deal [Aug-04-22 08:17AM] UPDATE 3-Amgen adds potential blockbuster drug with $3.7 bln ChemoCentryx deal [Aug-04-22 08:15AM] Amgen to Buy ChemoCentryx for $3.7 Billion [Aug-04-22 08:00AM] AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH [Aug-04-22 08:00AM] AMGEN APPOINTS MICHAEL V. DRAKE TO BOARD OF DIRECTORS [Aug-03-22 04:05PM] AMGEN ANNOUNCES 2022 THIRD QUARTER DIVIDEND [Aug-03-22 04:00PM] Companies That Offer the Biggest 401(k) Employer Match [Aug-03-22 10:38AM] Amgen Narrows Sales Outlook Following Plans To Acquire ChemoCentryx [Aug-04-22 04:21PM] AMGEN REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS [Aug-04-22 04:01PM] Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal [Aug-04-22 08:17AM] UPDATE 4-Amgen bets on ChemoCentryx's rare disease drug in $3.7 bln deal [Aug-04-22 08:15AM] Dow Jones Futures: Jobs Report Will Test Fed's Soft Landing; Tesla Stock Split Vote Due [Aug-04-22 06:23PM] Amgen to buy ChemoCentryx for billions in cash [Aug-04-22 05:23PM] ChemoCentrix Spikes 110% on Amgen Acquisition Deal [Aug-04-22 07:10PM] Dow Jones Futures: Jobs Report Will Test 'Soft Landing' Market Rally; Tesla Stock Split Approved [Aug-04-22 07:06PM] Amgen (AMGN) Q2 Earnings and Revenues Beat Estimates [Aug-04-22 05:25PM] DraftKings, Zillow, Lyft, AMC and Other Stock Market Movers [Aug-05-22 07:13AM] DraftKings, Zillow, Lyft, AMC, and Other Stock Market Movers [Aug-05-22 08:16AM] Dow Jones Futures: Jobs Report Tests 'Soft Landing' Market Rally; Tesla Stock Split Approved [Aug-05-22 08:12AM] Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx [Aug-05-22 09:45AM] Amgen's Q2 Sales Impacted By Lower Prices, Currency Headwind, Reaffirms FY22 Outlook [Aug-05-22 08:14AM]
27-04-2022	AH	4:00 PM ET (Apr 27)	AMGN	Amgen Inc.	134,600	4.25	4.21	3.70	Amgen Non-GAAP EPS of $4.25 beats by $0.12, revenue of $6.2B beats by $90M [4/27/2022 4:03 PM]	238.24	-10.55 (-4.24%)	238.40	-10.39 (-4.18%)	198.64 - 258.81	5,608,096	2,640,000	36,902
Amgen's Repatha sustains reduction in bad cholesterol as per long term data from 2 studies [4/27/2022 9:48 AM] Amgen Non-GAAP EPS of $4.25 beats by $0.12, revenue of $6.2B beats by $90M [4/27/2022 4:03 PM] Amgen posts Q1 beat driven by volumes even as Enbrel and Otezla sales decline [4/27/2022 4:29 PM] Drug/Biotech Stocks' Apr 27 Q1 Earnings Roster: GSK, AMGN & More [Apr-26-22 11:44AM] Healthcare ETFs in Focus Ahead of Q1 Earnings [Apr-26-22 11:15AM] The Zacks Analyst Blog Highlights Amgen, Chevron, Coca-Cola, Visa and Merck [Apr-26-22 05:50AM] Molecular Partners shares tumble 37% after Amgen returns rights to tumor treatment candidate [Apr-27-22 08:02AM] AMGEN ANNOUNCES RESULTS FROM TWO OPEN LABEL EXTENSION STUDIES OF REPATHA® (EVOLOCUMAB) [Apr-27-22 09:00AM] Molecular Partners Regains Rights To Early-Stage Cancer Asset From Amgen [Apr-27-22 06:01AM] AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS [Apr-27-22 04:01PM] Biotech Behemoth Amgen Tops First-Quarter Views, But 2022 Guidance Lags [Apr-27-22 04:14PM] Amgen says IRS seeks another $5.1 billion in back taxes [Apr-27-22 04:26PM] Amgen says IRS seeks billions in back taxes, shares fall 4% [Apr-27-22 04:34PM] UPDATE 1-Amgen says IRS seeks billions in back taxes, shares fall 4% [Apr-27-22 04:52PM] Amgen Q1 revenue beats expectations, profit declines [Apr-27-22 05:03PM] UPDATE 2-Amgen says IRS seeks billions in back taxes, shares fall 4% [Apr-27-22 04:52PM] UPDATE 3-Amgen says IRS seeks billions in back taxes, shares fall 6% [Apr-27-22 04:52PM] Amgen says IRS seeks billions in back taxes, shares fall 6% [Apr-27-22 04:34PM] Amgen (AMGN) Surpasses Q1 Earnings and Revenue Estimates [Apr-27-22 05:25PM] PRESS DIGEST- Wall Street Journal - April 28 [Apr-28-22 02:07AM] Amgen Falls After Revealing a $7 Billion IRS Tax Bill [Apr-28-22 04:51AM] Dow Jones Futures Jump As Facebook Soars On Earnings; Apple Earnings Due [Apr-28-22 08:23AM] Dow Jones Rallies As Facebook Soars 18% On Earnings; Apple Earnings Due [Apr-28-22 09:33AM] Amgen's Q1 Better Than Expected Sales, Profit Overshadowed By Tax Disclosure [Apr-28-22 06:30AM] Amgen's (AMGN) Q1 Earnings Top, Stock Down on IRS Tax Dispute [Apr-28-22 10:44AM] 11 Stocks Making Big Moves on Earnings Reports [Apr-28-22 01:44PM] Bizarre Potential $7.1 Billion Tax Bill Sinks Amgen Shares [Apr-28-22 01:33PM] Stocks set to erase losses from earlier in the week [Apr-28-22 04:21PM]
07-02-2022	AH	4:00 PM ET (Feb 7)	AMGN	Amgen Inc.	126,190	4.36	4.14	3.81	Amgen Non-GAAP EPS of $4.36 beats by $0.35, revenue of $6.85B misses by $20M [2/7/2022 4:02 PM]	241.02	17.49 (7.82%)	232.98	9.45 (4.23%)	198.64 - 261.00	7,496,906	3,000,000	172,249
Amgen Non-GAAP EPS of $4.36 beats by $0.35, revenue of $6.85B misses by $20M [2/7/2022 4:02 PM] Amgen net income rises ~18% YoY even as product revenue remained flat [2/7/2022 4:39 PM] Amgen sets lower than expected guidance for 2022; plans up to $6B buybacks in Q1 [2/8/2022 9:21 AM] Cowa, Llc Buys Avantis U.S. Small Cap Value ETF, Dimensional International Core Equity Market ... [Feb-04-22 05:38PM] Torray LLC Buys General Motors Co, T. Rowe Price Group Inc, Applied Materials Inc, Sells Intel ... [Feb-04-22 05:38PM] Centene (CNC) Gears Up for Q4 Earnings: What Lies Ahead? [Feb-04-22 11:41AM] Auxano Advisors, LLC Buys Costco Wholesale Corp, iShares MSCI Intl Quality Factor ETF, ... [Feb-04-22 09:38AM] Re Advisers Corp Buys Chevron Corp, Corning Inc, Boston Scientific Corp, Sells NVIDIA Corp, ... [Feb-07-22 09:38AM] Peloton, Spirit Airlines Jump off Deal Making Talks [Feb-07-22 10:54AM] Spirit Airlines Soars on $6.6 Billion Frontier Deal [Feb-07-22 11:09AM] CLARET ASSET MANAGEMENT Corp Buys Bristol-Myers Squibb Co, Shopify Inc, Hertz Global Holdings ... [Feb-07-22 01:38PM] DT Investment Partners, LLC Buys BTC iShares Intermediate Government/Credit Bond ET, Amgen Inc, ... [Feb-07-22 01:38PM] Amgen revenue up 3% with contribution from Lilly COVID antibody [Feb-07-22 04:03PM] Amgen Stock Remains In Limbo As Its Biggest Product Flounders [Feb-07-22 04:02PM] Amgen stock rises after COVID drugs boost Q4 profit [Feb-07-22 04:19PM] Dow Jones Futures In Focus; 4 Top Stocks To Buy And Watch In Volatile Stock Market Rally [Feb-07-22 04:53PM] Raab & Moskowitz Asset Management LLC Buys Vanguard Ultra-Short Bond ETF, Netflix Inc, ... [Feb-07-22 05:38PM] UPDATE 1-Amgen quarterly revenue rises; sales fall 1% on pricing pressure [Feb-07-22 05:56PM] Dow Jones Futures Rise; 4 Top Stocks To Buy And Watch In Volatile Stock Market Rally [Feb-07-22 06:04PM] Amgen (AMGN) Beats Q4 Earnings Estimates [Feb-07-22 05:25PM] Mixed Earnings Results for Amgen, TakeTwo; Chegg Jumps on Beat [Feb-07-22 05:58PM] Dow Jones Futures Fall; 4 Top Stocks To Buy And Watch In Volatile Stock Market Rally [Feb-08-22 06:55AM] AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING [Feb-08-22 08:36AM] Dow Jones Futures Rise; Drug Giant Pfizer Slides On Earnings [Feb-08-22 08:31AM] Dow Jones Rallies; Drug Giant Pfizer Slides On Earnings [Feb-08-22 09:36AM] Dow climbs 110 points, but broader stock market wavers Tuesday as 10-year yield nears 2% [Feb-08-22 09:41AM] Hikari Tsushin, Inc. Buys Lockheed Martin Corp, Altria Group Inc, Phillips 66, Sells Wells ... [Feb-08-22 09:38AM] Constitution Capital LLC Buys UnitedHealth Group Inc, Technology Select Sector SPDR ETF, ... [Feb-08-22 09:38AM] Amgen's stock surges to pace the Dow's gainers after plans to buy back up to $6 billion of its shares this quarter [Feb-08-22 09:54AM] AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS REVIEW [Feb-08-22 10:20AM] Market check: Stocks mixed, crude oil slides, pharmaceuticals swing on earnings [Feb-08-22 10:29AM] Amgen plans $6 bln share buyback in Q1, sees earnings doubling by 2030 [Feb-08-22 10:36AM] Amgen plans $6 billion share buyback in Q1, sees earnings doubling by 2030 [Feb-08-22 10:48AM] Amgen's (AMGN) Q4 Earnings Top Estimates, Product Sales Fall [Feb-08-22 10:12AM] Amgen Gaps Higher On Bullish 2030 Outlook; Why Some Are Questioning It [Feb-08-22 12:16PM] Amgen plans $6 billion share buyback this quarter, shares jump 8% [Feb-08-22 10:48AM] UPDATE 1-Amgen plans $6 bln share buyback this quarter, shares jump 8% [Feb-08-22 12:33PM] Pfizer (PFE) Q4 Earnings Top, 2022 Sales View Grim, Stock Down [Feb-08-22 10:56AM] Dow Jones Jumps 350 Points, Fueled By Amgen Breakout; Financial Stocks Follow 10-Year Yield Higher [Feb-08-22 01:38PM] US STOCKS-Wall Street rallies with Big Tech; banks up with Treasury yields [Feb-08-22 02:11PM] Amgen Inc. -- Moody's affirms Amgen at Baa1; outlook stable [Feb-08-22 02:09PM] Quadrant Private Wealth Management, LLC Buys VanEck Gold Miners ETF, The Walt Disney Co, Amgen ... [Feb-08-22 02:38PM] Border to Coast Pensions Partnership Ltd Buys PayPal Holdings Inc, Big Lots Inc, Fiserv Inc, ... [Feb-08-22 02:38PM] MTM Investment Management, LLC Buys PowerShares QQQ Trust Ser 1, FIRST TR SMALL CAP, Amplify ... [Feb-08-22 02:38PM] Boyer & Corporon Wealth Management, LLC Buys The Walt Disney Co, iShares MSCI Brazil ETF, ... [Feb-08-22 02:38PM] UPDATE 2-Amgen to buy back $6 bln in shares this qtr, provides long-term profit forecast [Feb-08-22 12:33PM] Dow Jones, Nasdaq Rally While Small-Caps Lead Upside; Oil Sells Off [Feb-08-22 03:38PM] Dow Jones, Nasdaq Close At Highs While Small-Caps Lead Upside; Oil Sells Off [Feb-08-22 04:27PM] US STOCKS-Wall Street ends higher; bank stocks rise with Treasury yields [Feb-08-22 04:14PM] US STOCKS-Wall Street ends higher; bank stocks rise with Treasury yields [Feb-08-22 04:00PM]
02-11-2021	AH	4:00 PM ET (Nov 2)	AMGN	Amgen Inc.	117,640	4.67	4.20	4.37	Amgen EPS beats by $0.45, beats on revenue [11/2/2021 4:04 PM]	218.29	4.04 (1.88%)	210.29	-3.97 (-1.85%)	200.47 - 276.69	2,724,194	2,240,000	205,310
Amgen EPS beats by $0.45, beats on revenue [11/2/2021 4:04 PM] Amgen Q3 non-GAAP net income rises 8% YoY driven by 4% increase in revenues [11/2/2021 4:36 PM] BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors [Nov-02-21 09:00AM] Amgen Reports Third Quarter 2021 Financial Results [Nov-02-21 04:01PM] Amgen 3rd quarter profit beats, sales rise 4% [Nov-02-21 04:18PM] Amgen Dips Despite Third-Quarter Beat With Sales Guidance Just In Line [Nov-02-21 04:28PM] Amgen still sees pandemic impact, with fewer patients starting treatments [Nov-02-21 04:37PM] Amgen posts higher third-quarter sales, but trims full-year estimate [Nov-02-21 04:18PM] UPDATE 1-Amgen posts higher third-quarter sales, but trims full-year estimate [Nov-02-21 05:00PM] Amgen Stock Dips On Mixed Outlook For 2021 Despite Its Third-Quarter Beat [Nov-02-21 05:25PM] UPDATE 2-Amgen posts higher third-quarter sales, but trims full-year estimate [Nov-02-21 05:00PM] Amgen (AMGN) Q3 Earnings and Revenues Top Estimates [Nov-02-21 05:25PM] Amgen Inc. (AMGN) Q3 2021 Earnings Call Transcript [Nov-03-21 12:31AM] 5 Stocks To Watch For November 3, 2021 [Nov-03-21 03:20AM] 2 Incredibly Cheap Dividend Stocks to Buy Now [Nov-03-21 10:00AM] Amgen (AMGN) Q3 Earnings Top, Sales View Tightened, Stock Down [Nov-03-21 11:28AM] 10 Best Cancer Stocks To Buy Now [Nov-03-21 03:25PM] Amgen CEO says U.S. Medicare out-of-pocket cap will improve access [Nov-03-21 04:01PM] Amgen CEO says U.S. Medicare out-of-pocket cap will improve access [Nov-03-21 03:57PM]
03-08-2021	AH	4:00 PM ET (Aug 3)	AMGN	Amgen Inc.	138,780	4.38	4.13	4.25	Amgen EPS beats by $0.37, beats on revenue, boost buyback [8/3/2021 4:02 PM]	228.74	-15.34 (-6.28%)	238.53	-5.55 (-2.27%)	210.28 - 276.69	6,324,305	1,830,000	5,352
Amgen EPS beats by $0.37, beats on revenue, boost buyback [8/3/2021 4:02 PM] Amgen lowers 2021 earnings guidance despite revenue beat [8/3/2021 4:40 PM] Amgen (AMGN) Option Traders Unenthusiastic Into Earnings [Aug-02-21 05:21PM] Drug/Biotech Stock Q2 Earnings on Aug 3: LLY, AMGN & More [Aug-02-21 09:36AM] Amgen says it expects pandemic to limit sales through 2021 [Aug-03-21 04:07PM] Amgen Stock Dips Despite Second-Quarter Beat, Guidance Reiterated [Aug-03-21 04:20PM] UPDATE 1-Amgen says it expects pandemic to limit sales through 2021 [Aug-03-21 04:34PM] Amgen says fewer doctor visits, lab tests amid pandemic still affecting its business [Aug-03-21 04:31PM] Dow Jones Jumps Back Above 35,000 -- This Could Push It Back to Record Levels Soon [Aug-03-21 04:20PM] Amgen Stock: Second-Quarter Earnings Top Estimates, Revenue up 5% [Aug-03-21 12:40PM] Amgen Reports Second Quarter 2021 Financial Results [Aug-03-21 04:01PM] Amgen Stock Dips On Guidance Trim Despite Second-Quarter Beat [Aug-03-21 05:22PM] UPDATE 2-Amgen says it expects pandemic to limit sales through 2021 [Aug-03-21 04:34PM] Why Did These 2 Growth Stocks Fall Tuesday Night? [Aug-03-21 06:09PM] Amgen (AMGN) Surpasses Q2 Earnings and Revenue Estimates [Aug-03-21 05:15PM] Amgen inc (AMGN) Q2 2021 Earnings Call Transcript [Aug-03-21 10:31PM] Dow Jones Today, Futures Dip Ahead Of July Hiring Data; FDA Timeline Lifts BioNTech; Paycom, DaVita Eye Breakouts [Aug-04-21 08:17AM] Dow Jones Today, Futures Dip; July Hiring Data Weak; FDA Timeline Lifts BioNTech; Paycom, DaVita Eye Breakouts [Aug-04-21 08:26AM] Dow Jones Today, Futures Slump As July Hiring Data Disappoints; FDA Timeline Lifts BioNTech; Paycom, DaVita Eye Breakouts [Aug-04-21 08:44AM] GM, Kraft Heinz Fall Premarket; Live Nation, Robinhood Rise [Aug-04-21 04:12AM] Dow Jones Today, Stocks Slump As July Hiring Data Disappoints; FDA Timeline Lifts BioNTech; Paycom, DaVita Eye Breakouts [Aug-04-21 09:43AM] Dow Jones Drops Amid Weak Jobs Report, But Cathie Wood Boosts This IPO Stock [Aug-04-21 10:42AM] Dow Jones Today, Stocks Slump As July Hiring Data Disappoints; FDA Timeline Lifts BioNTech; Paycom, DaVita Ace Breakouts [Aug-04-21 10:30AM] Amgen (AMGN) Q2 Earnings Top, COVID-Led Sales Woes to Linger [Aug-04-21 09:52AM] Dow Jones Drops On Weak Jobs Report, But Cathie Wood Boosts This IPO Stock [Aug-04-21 10:42AM] Dow Jones Loses 300 Points On Weak Jobs Data But Covid Stocks, Recent IPO Soar [Aug-04-21 12:15PM] Why Amgen Is Down Nearly 7% Today [Aug-04-21 03:30PM] Amgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance Plant [Aug-04-21 02:44PM]
27-04-2021	AH	4:00 PM ET (Apr 27)	AMGN	Amgen Inc.	148,000	3.70	4.00	4.17	Amgen EPS misses by $0.34, misses on revenue [4/27/2021 4:04 PM]	236.40	-18.72 (-7.34%)	243.50	-11.63 (-4.56%)	210.28 - 276.69	6,809,756	2,280,000	23,691
Amgen EPS misses by $0.34, misses on revenue [4/27/2021 4:04 PM] Amgen shares fall 5% after hours following Q1 sales decline, earnings miss [4/27/2021 4:30 PM] Amgen updates on LUMAKRAS dose comparison study [4/28/2021 10:40 AM] Amgen Reports Results From Otezlas Phase 3 Trial For Treatment Of Plaque Psoriasis [Apr-26-21 08:17AM] Does This First-in-Class Acquisition Make Amgen a Buy? [Apr-27-21 06:54AM] Amgen Reports First Quarter 2021 Financial Results [Apr-27-21 04:01PM] UPDATE 1-Amgen 1st-quarter profit, sales fall; lower drug prices cited [Apr-27-21 04:13PM] Amgen first-quarter profit, sales fall; lower drug prices cited [Apr-27-21 04:09PM] Amgen 1st-quarter profit, sales fall; lower drug prices cited [Apr-27-21 04:03PM] Amgen Stock Dips On Lighter-Than-Expected First-Quarter Sales, Profit [Apr-27-21 04:11PM] UPDATE 2-Amgen 1st-quarter profit, sales fall; lower drug prices cited [Apr-27-21 04:13PM] Amgen Crumbles On What One Analyst Calls 'The Ugliest' Quarter In Years [Apr-27-21 05:23PM] Amgen (AMGN) Lags Q1 Earnings and Revenue Estimates [Apr-27-21 05:15PM] Why Amgens Earnings Disappointed [Apr-27-21 06:00PM] Amgen profit, sales fall on lower drug prices; shares drop 3.4% [Apr-27-21 04:09PM] UPDATE 3-Amgen profit, sales fall on lower drug prices; shares drop 3.4% [Apr-27-21 04:13PM] Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript [Apr-28-21 12:31AM] Amgen Provides Updated Information On LUMAKRAS (Sotorasib)¹ Dose Comparison Study [Apr-28-21 03:33AM] Why Amgen's Q1 Results Disappointed Investors [Apr-28-21 06:01AM] What's Behind Teva's Mixed Q1 Results [Apr-28-21 10:55AM] Amgen (AMGN) Q1 Earnings, Sales Miss on Low Prices, Stock Down [Apr-28-21 10:17AM] Amgen Shares Drop On Light First Quarter Earnings Hit By Lower Prices [Apr-28-21 08:38AM] Amgen Drops; FDA Urges Post-Marketing Study for Drug Candidate [Apr-28-21 08:07AM] Dow Jones Drops As 3 Key Stocks Weigh; Will Apple Earnings Beat After The Close? [Apr-28-21 12:16PM] US STOCKS-Dow, Nasdaq weighed down by Microsoft, Amgen; all eyes on Fed [Apr-28-21 12:34PM] Amgens 1Q Results Disappoint; Shares Drop 8% [Apr-28-21 12:24PM] Biotech Stock Roundup: BIIB, AMGN's Q1 Earnings Updates & Other Pipeline News [Apr-28-21 12:18PM] Why Amgen Stock Is Plummeting Today [Apr-28-21 03:28PM]
02-02-2021	AH	4:00 PM ET (Feb 2)	AMGN	Amgen Inc.	140,550	3.81	3.36	3.64	Amgen EPS beats by $0.47, beats on revenue [2/2/2021 4:04 PM]	237.52	-2.97 (-1.24%)	234.00	-6.49 (-2.70%)	177.05 - 276.69	3,748,128	2,754,523	27,756
Amgen EPS beats by $0.47, beats on revenue [2/2/2021 4:04 PM] Amgen is under pressure as Baird calls FY21 guidance ‘a bit disappointing’ [2/3/2021 2:27 PM] US STOCKS-Wall Street rally cools after two-day climb; Alphabet jumps [Feb-03-21 12:03PM] The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision [Feb-03-21 07:31AM] Amgen Earnings Meet Expectations, but Its 2021 Outlook Isnt Inspiring Investors [Feb-02-21 06:00PM] Amgen issues 2021 outlook below Street view, shares dip [Feb-02-21 04:15PM]
28-10-2020	AH	4:00 PM ET (Oct 28)	AMGN	Amgen Inc.	131,720	4.37	3.75	3.66	Amgen EPS beats by $0.62, beats on revenue [10/28/2020 4:05 PM]	217.82	1.44 (0.67%)	213.69	-2.69 (-1.24%)	177.05 - 264.97	2,853,977	2,344,301	12,697

28-07-2020	AH	4:00 PM ET (Jul 28)	AMGN	Amgen Inc.	149,210	4.25	3.81	3.97	Amgen EPS beats by $0.48, beats on revenue, guidance reaffirmed [7/28/2020 4:03 PM]	247.92	-7.34 (-2.88%)	251.50	-3.77 (-1.48%)	174.27 - 264.97	1,626,469	1,928,666	30,253